Innovent Oncology: Integrated Cancer Solutions

Situation

Cancer costs become unsustainable with majority of costs derived from three categories: treatment selection, patient health status between office visits, and treatment applications near the end of life.
Growing preference within payer community for clinical evidence to drive treatment selection as basis for change in drug margin economics
Legacy third-party disease management programs produce disappointing ROI and minimal physician/patient benefits
Organized response from community oncologists is a compelling opportunity

Primary corporate services are administrative support of oncology practices with organizational resources and intellect spread across disparate business units
Physician customers dispersed in several geographic markets with emphasis on independent service delivery
No business vehicle to harness intellectual property into coordinated service offerings

Focused organization around three primary cost drivers which could be mitigated via an oncologist-centric business model and packaged for the payer community
Presented unique business model which promoted organizational focus on development, pilot testing, and launch phases
Created innovative physician-centric “Integrated Cancer Solutions” service concept including brand name “Innovent Oncology” and launch communications

New service launches occurring in several locations
Market acceptance and uptake from top national payers
Both payers and oncologists see program value and benefit by organizing services, data and reimbursement to collectively address treatment selection, patient support and end-of-life planning